From machine learning to deep learning: progress in machine intelligence for rational drug discovery

L Zhang, J Tan, D Han, H Zhu - Drug discovery today, 2017 - Elsevier
Highlights•Six commonly used machine learning methods in QSAR models are
summarized.•Newly developed combinatorial QSAR and hybrid QSAR methods are …

[HTML][HTML] In vitro and ex vivo models in inhalation biopharmaceutical research—advances, challenges and future perspectives

MA Selo, JA Sake, KJ Kim, C Ehrhardt - Advanced Drug Delivery Reviews, 2021 - Elsevier
Oral inhalation results in pulmonary drug targeting and thereby reduces systemic side
effects, making it the preferred means of drug delivery for the treatment of respiratory …

A boiled‐egg to predict gastrointestinal absorption and brain penetration of small molecules

A Daina, V Zoete - ChemMedChem, 2016 - Wiley Online Library
Apart from efficacy and toxicity, many drug development failures are imputable to poor
pharmacokinetics and bioavailability. Gastrointestinal absorption and brain access are two …

[HTML][HTML] Real-time release testing of dissolution based on surrogate models developed by machine learning algorithms using NIR spectra, compression force and …

DL Galata, Z Könyves, B Nagy, M Novák… - International Journal of …, 2021 - Elsevier
In this work spectroscopic measurements, process data and Critical Material Attributes
(CMAs) are used to predict the in vitro dissolution profile of sustained-release tablets with …

High throughput read-across for screening a large inventory of related structures by balancing artificial intelligence/machine learning and human knowledge

C Yang, JF Rathman, A Mostrag… - Chemical Research …, 2023 - ACS Publications
Read-across is an in silico method applied in chemical risk assessment for data-poor
chemicals. The read-across outcomes for repeated-dose toxicity end points include the no …

[PDF][PDF] Archive of SID. ir

AM Najar, A Eswayah, MB Moftah, RO MK, E Bobtaina… - 2023 - sid.ir
We [1, 2] and others [3- 5] have been interested in designing and making new molecules
that have biological activities, medicinal uses, coordination behaviors [6- 8] and studying …

Use of big data in drug development for precision medicine: an update

T Qian, S Zhu, Y Hoshida - … review of precision medicine and drug …, 2019 - Taylor & Francis
Introduction: Big-data-driven drug development resources and methodologies have been
evolving with ever-expanding data from large-scale biological experiments, clinical trials …

The trends and future prospective of in silico models from the viewpoint of ADME evaluation in drug discovery

H Komura, R Watanabe, K Mizuguchi - Pharmaceutics, 2023 - mdpi.com
Drug discovery and development are aimed at identifying new chemical molecular entities
(NCEs) with desirable pharmacokinetic profiles for high therapeutic efficacy. The plasma …

Simulation models for prediction of bioavailability of medicinal drugs—the interface between experiment and computation

ME Soliman, AT Adewumi, OB Akawa, TI Subair… - AAPS …, 2022 - Springer
The oral drug bioavailability (BA) problems have remained inevitable over the years,
impairing drug efficacy and indirectly leading to eventual human morbidity and mortality …

[HTML][HTML] In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2

SK Chidambaram, D Ali, S Alarifi… - Journal of Infection and …, 2020 - Elsevier
Background The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …